Dolly technology sold for Pounds 20 million to US

May 7, 1999

This week's sale of the technology behind Dolly, the first cloned sheep, to an American biotech company should bring more than Pounds 20 million to the institute where she was born, it is estimated. The purchase of Roslin Bio-Med by California's Geron Corporation, which sponsored the scientists who last year cultivated human embryonic stem cells, should accelerate the development of new transplantation therapies for numerous degenerative diseases.

Please login or register to read this article

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments